Huntington National Bank Purchases Shares of 2,630 DENTSPLY SIRONA Inc. (XRAY)

Huntington National Bank purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,630 shares of the medical instruments supplier’s stock, valued at approximately $157,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Veritas Asset Management LLP increased its stake in DENTSPLY SIRONA by 2.6% in the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after purchasing an additional 157,616 shares in the last quarter. Royce & Associates LP increased its stake in DENTSPLY SIRONA by 23.4% in the second quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock valued at $8,212,000 after purchasing an additional 24,000 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its stake in DENTSPLY SIRONA by 78.7% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock valued at $771,000 after purchasing an additional 5,236 shares in the last quarter. Gateway Investment Advisers LLC increased its stake in DENTSPLY SIRONA by 8.4% in the second quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock valued at $1,258,000 after purchasing an additional 1,499 shares in the last quarter. Finally, Delta Lloyd Asset Management N.V. bought a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $15,624,000. 93.92% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Huntington National Bank Purchases Shares of 2,630 DENTSPLY SIRONA Inc. (XRAY)” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.com-unik.info/2017/11/01/huntington-national-bank-purchases-shares-of-2630-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (XRAY) opened at 61.07 on Wednesday. The firm’s market cap is $14.02 billion. The stock has a 50 day moving average of $59.20 and a 200 day moving average of $60.94. DENTSPLY SIRONA Inc. has a 12-month low of $52.53 and a 12-month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, meeting the consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.76 EPS. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

Several equities research analysts have commented on XRAY shares. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a research note on Thursday, July 13th. HC Wainwright started coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price for the company. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Wednesday, July 19th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $69.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. Three research analysts have rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $65.60.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit